We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XWEL icon
2601
XWELL
XWEL
$8.95M
$741K ﹤0.01%
18,332
+17,714
+2,866% +$561K
SRI icon
2602
Stoneridge
SRI
$206M
$740K ﹤0.01%
+37,480
New +$792K
FXI icon
2603
PUT
iShares China Large-Cap ETF
FXI
$4.3B
$739K ﹤0.01%
+20,200
New +$793K
REPX icon
2604
Riley Exploration Permian
REPX
$717M
$734K ﹤0.01%
37,988
+796
+2% +$17.7K
THWWW
2605
CALL
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$734K ﹤0.01%
206,200
+44,400
+27% +$17.4K
HES
2606
DELISTED
Hess
HES
$731K ﹤0.01%
+9,865
New +$800K
ENTA icon
2607
Enanta Pharmaceuticals
ENTA
$365M
$723K ﹤0.01%
+9,670
New +$759K
SEDA.WS
2608
CALL
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$723K ﹤0.01%
+74,241
New +$38.9K
CAH icon
2609
Cardinal Health
CAH
$54.6B
$721K ﹤0.01%
13,990
-35,936
-72% -$1.76M
IMAX icon
2610
IMAX
IMAX
$2.58B
$721K ﹤0.01%
+40,427
New +$775K
NGVC icon
2611
Vitamin Cottage Natural Grocers
NGVC
$753M
$721K ﹤0.01%
50,595
+1,822
+4% +$23.4K
OLMA icon
2612
Olema Pharmaceuticals
OLMA
$989M
$721K ﹤0.01%
77,092
+31,514
+69% +$653K
XLV icon
2613
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$718K ﹤0.01%
5,100
KWAC
2614
DELISTED
Kingswood Acquisition Corp.
KWAC
$717K ﹤0.01%
71,113
LITS
2615
Lite Strategy Inc
LITS
$32.4M
$712K ﹤0.01%
+13,329
New +$744K
GP
2616
GreenPower Motor Co
GP
$10.6M
$708K ﹤0.01%
+7,474
New +$967K
AGILW
2617
CALL
DELISTED
AgileThought Inc Warrant
AGILW
$708K ﹤0.01%
150,000
TCMD icon
2618
Tactile Systems Technology
TCMD
$624M
$707K ﹤0.01%
+37,171
New +$1.05M
UHGWW
2619
CALL
DELISTED
United Homes Group Warrant
UHGWW
$706K ﹤0.01%
72,512
YEXT icon
2620
Yext
YEXT
$565M
$705K ﹤0.01%
70,996
-373,291
-84% -$4.19M
WHWK
2621
Whitehawk Therapeutics
WHWK
$181M
$704K ﹤0.01%
+29,173
New +$733K
HRZN icon
2622
Horizon Technology Finance
HRZN
$296M
$702K ﹤0.01%
+44,072
New +$744K
GCO icon
2623
Genesco
GCO
$420M
$701K ﹤0.01%
+10,918
New +$693K
PFSW
2624
DELISTED
PFSweb, Inc.
PFSW
$701K ﹤0.01%
54,413
-8,700
-14% -$112K
WSC icon
2625
WillScot Mobile Mini Holdings
WSC
$4.38B
$700K ﹤0.01%
+17,157
New +$633K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.